[1]
|
D. L. Chengelis, P. J. Bendick, J. L. Glover, O. W. Brown and T. J. Ranval, “Progression of Superficial Venous Thrombosis to Deep Vein Thrombosis,” Journal of Vascular Surgery, Vol. 24, No. 5, 1996, pp. 745-749.
doi:10.1016/S0741-5214(96)70007-1
|
[2]
|
E. Olsson and P. H?ijer, “Activated Protein C Resistance Due to Factor V Leiden, Elevated Coagulation Factor VIII and Postoperative Deep Vein Thrombosis in Late Breast Reconstruction with a Free TRAM Flap: A Report of Two Cases,” British Journal of Plastic Surgery, Vol. 58, No. 5, 2005, pp. 720-723.
doi:10.1016/j.bjps.2004.12.024
|
[3]
|
I. C. Warnecke, F. Kretschmer, S. Brüner, O. Frerichs and H. Fansa, “Hereditary Thrombophilia in Free Microvascular Flaps—A Case Report,” Handchirurgie Mikrochirurgie Plastische Chirurgie, Vol. 39, No. 3, 2007, pp. 220-224. doi:10.1055/s-2007-965139
|
[4]
|
N. A. Mikirova, T. E. Ichim and N. Riordan, “Anti-Angiogenic Effect of High Doses of Ascorbic Acid,” Journal of Translational Medicine, Vol. 6, 2008, pp. 50-65.
doi:10.1186/1479-5876-6-50
|
[5]
|
Q. Chen, M. G. Espey, A. Y. Sun, J. H. Lee, M. C. Krishna, E. Shacter, P. L. Choyke, C. Pooput, K. L. Kirk, G. R. Buettner and M. Levine, “Ascorbate in Pharmacologic Concentrations Selectively Generates Ascorbate Radical and Hydrogen Peroxide in Extracellular Fluid in Vivo,” Proceedings of the National Academy of Sciences, Vol. 104, No. 21, 2007, pp. 8749-8754.
doi:10.1073/pnas.0702854104
|
[6]
|
B. Peterkofsky and W. Prather, “Cytotoxicity of Ascorbate and Other Reducing Agents towards Cultured Fibroblasts as a Result of Hydrogen Peroxide Formation,” Journal of Cellular Physiology, Vol. 90, No. 1, 1977, pp. 61-70. doi:10.1002/jcp.1040900109
|
[7]
|
H. D. Jampel, “Ascorbic Acid Is Cytotoxic to Dividing Human Tenon’s Capsule Fibroblasts. A Possible Contributing Factor in Glaucoma Filtration Surgery Success,” Archives of Ophthalmology, Vol. 108, No. 9, 1990, pp. 1323-1325. doi:10.1001/archopht.1990.01070110139038
|